Major UK project launched to tackle drug-resistant superbugs with AI

A major UK project has launched to combat drug-resistant superbugs using artificial intelligence (AI). This collaboration, led by the Fleming Initiative and GSK, aims to accelerate the discovery of new antibiotics and combat deadly fungal infections. With a £45m investment, researchers including Dr. Andrew Edwards from Imperial College London will focus on utilizing AI to target Gram-negative bacteria, known for their resistance mechanisms. This innovative approach may provide a solution to the escalating crisis of drug-resistant infections globally.